From: A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model
Annual cost associated with treatment
Dutasteride US$
Fixed dose therapy US$
Moderate BPH
338.82
Cost generated from cost data in two regional tertiary health centres in Nigeria
Severe BPH
223.53
TURP
484.97
AUR
29.41